Abstract:Objective To investigate the changes of serum adiponectin and visfatin/pre-B cell colony-enhan cing factor(PBEF)levels in patients with metabolic syndrome(MS),so as to understand their association with MS.Methods According to the diagnostic criteria for MS recommended by the Chinese Medical Association in 2004,42 patients with MS were selected for this study with 30 healthy subjects as the control group.After mea- surement of the height,body weight and waist circumference,fasting blood samples were collected from all partici- pants to determine the fasting plasma glucose(FPG),serum insulin,adiponectin and visfatin levels.Radioimmuno- assay(RIA)was employed for serum adiponectin level measurement;enzyme-linked immunoassay(EIA)was used for visfatin detection;and homeostasis model assessment of insulin resistance(HOMA-IR)was calculated based on FPG and insulin measurements.Results①There were 22 males and 20 females in the MS group,with a mean age of(53±10)years old;there were 18 males and 12 females in the control group,with a mean age of(49±10) years.The ages and sex structure were matchable between the two groups(both P>0.05).②Serum visfatin levels was significantly higher in the MS patients than in the control subjects([97.57±40.69]μg/L vs [50.54±19.14]μg/L,P<0.05),but the adiponectin level was significantly lower([7.98±3.62] mg/L vs [13.55±5.72] mg/L,P<0.01).③In patients with MS,serum visfatin level was positively correlated with the waist circumference(Satandard partial regression cofficient=0.415,P=0.000),but not with other metabolic indices such as adiponectin,serum insulin,body mass index,HOMA-IR,or triglycerol;adiponectin level was positively correlated with high-density lipoprotein cholesterol(HDL-C)level(Satandard partial regression cofficient=0.312, P=0.004)but inversely with HOMA-IR(Satandard partial regression cofficient=-0.341,P=0.002)and the waist-hip ratio(Satandard partial regression cofficient=-0.211,P=0.048).Conclusions Significantly elevated visfatin and decreased adiponeetin levels occur in MS patients.Visfatin may play a role in the development of viscer al obesity,and adiponectin may inhibit insulin resistance and dyslipidiemia.No obvious correlation between visfatin and adiponectin is suggested.

Serum Levels of Adiponectin Are Strongly Associated with Lipoprotein Subclasses in Healthy Volunteers but Not in Patients with Metabolic Syndrome

Advanced Oxidation Protein Products Are Strongly Associated with the Serum Levels and Lipid Contents of Lipoprotein Subclasses in Healthy Volunteers and Patients with Metabolic Syndrome

Serum vitamin D levels are inversely related with non-alcoholic fatty liver disease independent of visceral obesity in Chinese postmenopausal women.

Reduced circulating adiponectin levels are associated with the metabolic syndrome independently of obesity, lipid indices and serum insulin levels: a cross-sectional study

Serum phospholipid fatty acid and insulin resistance in patients with metabolic syndrome

Angiopoietin-like Protein 3 and Adiponectin Levels in Patients with Metabolic Syndrome.

Correlation of serum visfatin and adiponectin levels with metabolic syndrome

[Correlation of Plasma Adiponectin and Components of Metabolic Syndrome].

Serum betatrophin level increased in subjects with metabolic syndrome: a case-control study

Association of Triglyceride with Serum Polyunsaturated Fatty Acid in Patients with Metabolic Syndrome

Serum Adiponectin Levels as an Independent Marker of Severity of Psoriasis: A Cross-Sectional Analysis

Associations of Adipokine Levels With Levels of Remnant Cholesterol: The Multi-Ethnic Study of Atherosclerosis

Serum adiponectin concentration and cardiovascular risk factors in climacteric women

Serum Adiponectin Predicts COVID-19 Severity

Relationship between adiponectin and muscle mass in patients with metabolic syndrome and obesity

Meta-Analysis of Adiponectin As a Biomarker for the Detection of Metabolic Syndrome

Serum Levels of Lipid and Apolipoprotein in Coronary Heart Disease Patients with Metabolic Syndrome

Association of Adipokines with Cardiac Abnormalities in Patients with Metabolic Syndrome

Association of Serum Vaspin Concentration with Metabolic Disorders in Obese Individuals

Serum Adiponectin Levels in Adult Male Patients with Obstructive Sleep Apnea Hypopnea Syndrome

Hypoadiponectinemia is associated with Non-alcoholic fatty liver disease and metabolic syndrome